Skip to main content
. 2019 Dec 11;14(6):504–514. doi: 10.4103/1735-5362.272537

Fig. 2.

Fig. 2

Kaplan-Meier analysis for comparing 1-month patients’ survivals between L-carnitin and placebo groups of the study. One-month patients’ survival was significantly higher in L-carnitine group compared with placebo group (97% vs. 74.4%; P = 0.008).